drugset / Trial / NCT01404364

Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

NCT01404364

Completed 36 enrolled Hospital Governador Celso Ramos
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the efficacy of intravitreal triamcinolone and retrobulbar chlorpromazine as alternatives in the management of ocular pain in blind eyes.

Timeline

Start
2010-01
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorpromazine Small molecule 2.5 ml Other
Comparator Triamcinolone Other / unclassified 0.3 ml Intravitreal